Advertisement
Screener

AMERICAN SHARED HOSPITAL SERVICES (AMS) Foreign Currency Transaction Gain, before Tax

2.8 / 5 stars · 68/120 Roast Me

AMERICAN SHARED HOSPITAL SERVICES Foreign Currency Transaction Gain, before Tax

AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Foreign Currency Transaction Gain, before Tax of $161.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-04-01.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:ForeignCurrencyTransactionGainBeforeTax · last filed 2015-11-12

  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction gain, before tax for the quarter ending 2014-12-31 was $0.00.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction gain, before tax for the quarter ending 2014-09-30 was $0.00.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction gain, before tax for the quarter ending 2014-06-30 was $146.00K.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction gain, before tax for the quarter ending 2014-03-31 was $15.00K.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction gain, before tax for fiscal 2014 was $161.00K, a 86.29% decline from fiscal 2013.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction gain, before tax for fiscal 2013 was $1.17M, a 789.39% increase from fiscal 2012.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction gain, before tax for fiscal 2012 was $132.00K, a 388.89% increase from fiscal 2011.
  • AMERICAN SHARED HOSPITAL SERVICES foreign currency transaction gain, before tax for fiscal 2011 was $27.00K.
Period endForeign Currency Transaction Gain, before Tax 3 monthForeign Currency Transaction Gain, before Tax 6 monthForeign Currency Transaction Gain, before Tax 9 monthForeign Currency Transaction Gain, before Tax 12 monthForeign Currency Transaction Gain, before Tax 12 month as first filed
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-01
$0.00
derived: sum of 2 quarters · filed 2015-11-12
$146.00K
derived: sum of 3 quarters · filed 2015-11-12
$161.00K
10-K · filed 2015-04-01
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
$146.00K
derived: sum of 2 quarters · filed 2015-11-12
$161.00K
10-Q · filed 2015-11-12
2014-06-30$146.00K
10-Q · filed 2015-08-19
$161.00K
10-Q · filed 2015-08-19
2014-03-31$15.00K
10-Q · filed 2015-05-14
2013-12-31$1.17M
10-K · filed 2015-04-01
2012-12-31$132.00K
10-K · filed 2015-04-01
$133.00K
10-K · filed 2013-03-29
2011-12-31$27.00K
10-K · filed 2014-03-31
2010-12-31$0.00
10-K · filed 2013-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45